More Ways to Connect
  LinkedIn Twitter YouTube Instagram
Pier Paolo Scaglioni, MD, has been named professor and chief of the Division of Hematology Oncology in the Department of Internal Medicine.

Pier Paolo Scaglioni, MD, has been named professor and chief of the Division of Hematology Oncology in the Department of Internal Medicine.
Back Next
Publish Date: 09/11/17
Media Contact: Katie Pence, 513-558-4561
PDF download
RSS feed
related news
share this
Scaglioni Named Hematology Oncology Division Chief

CINCINNATI—Pier Paolo Scaglioni, MD, associate professor in the Division of Hematology Oncology at the University of Texas (UT) Southwestern, Dallas, has been named professor and chief of the Division of Hematology Oncology in the Department of Internal Medicine at the University of Cincinnati (UC) College of Medicine effective Jan. 8, 2018, pending approval by the UC Board of Trustees. 

"We are extremely excited to bring Dr. Scaglioni to UC to serve as a leader within our college and the university as a whole,” says William Ball, MD, UC senior vice president for health affairs and dean of the UC College of Medicine. "He is known nationally and internationally as a talented researcher, oncologist and educator, and we are thrilled to work with him to promote our cancer programs and ensure that we are successful in growing our efforts to achieve National Cancer Institute (NCI) designation.”

NCI designation is the highest recognition for an academic cancer center, opening doors to expanded research funding and related economic benefits and jobs, and bringing the most advanced cancer care to patients. UC is working toward gaining this distinction.  

Scaglioni, who will also hold the Herbert F. Koch Endowed Chair and will serve as a leader within the UC Cancer Institute, currently leads the Cancer Signaling Laboratory of the Simmons Cancer Center at UT Southwestern while holding a limited teaching practice within the Malignant Hematology/Bone Marrow Transplant program. At UC, he will also spend most of his time as a researcher within the lab and will continue to see patients within the UC Health system. 

Scaglioni will work to expand clinical cancer services at UC Health, develop innovative clinical and translational research studies, increase the number and types of clinical trials, strengthen multidisciplinary tumor boards and increase molecular oncology, with a focus on both personalized therapeutics and immuno-oncology. To help meet these goals, Scaglioni will be growing the division with the recruitment of additional faculty. 

"I’m excited to join the UC College of Medicine as a faculty member and a leader, and I am looking forward to advancing the already excellent research, clinical and educational missions currently in place,” says Scaglioni. "My priorities will be focused on the academic and clinical development of the cancer programs, as well as serving students, residents, fellows and the community at large.” 

"We are honored to have Dr. Scaglioni join the department and serve as a leader of the division of hematology oncology,” says Gregory Rouan, MD, Gordon and Helen Taylor Professor and Chair of the Department of Internal Medicine. "His translational research expertise will not only complement the current divisional portfolio and that of the department and college but also the needed leadership toward NCI designation. We all owe a debt of gratitude to Dr. Tahir Latif (professor in the division) who served as interim chief for his excellent management of the division. His leadership allowed for not only stability but also growth in each of the missions of the division.”

Scaglioni received his medical degree in 1989 from the University of Modena, Italy. After completing a residency in internal medicine at the University of Modena in 1993, he joined the laboratory of Jack Wands, MD, at the Massachusetts General Hospital Cancer Center as a post-doctoral associate studying the mechanisms leading to hepatitis B virus-induced liver disease. 

Scaglioni completed his U.S. internal medicine residency at the Montefiore Medical Center/Albert Einstein College of Medicine (1998-2001) and a fellowship in hematology oncology at the Memorial Sloan-Kettering Cancer Center (2001-2005). During oncology training, he focused his interests on blood cancers, and in 2002, he joined the laboratory of Pier Paolo Pandolfi, MD, PhD, at Memorial Sloan Kettering where he initiated studies to uncover the mechanisms controlling the Promyelocytic Leukemia (cancer of the white blood cells) gene tumor suppression function. 

In 2005, Scaglioni joined the hematology service of Memorial-Sloan Kettering Cancer Center as a faculty member, and in 2006, he became an assistant professor in the Division of Hematology/Oncology, Department of Medicine, at UT Southwestern Medical Center. 

Scaglioni has received many influential awards including the American Society of Clinical Oncology (ASCO) Young Investigator Award, the Cancer and Leukemia Group B (CALGB) Oncology Fellows Award, the Michael and Ethel L. Cohen Fellowship, the Charles A. Dana Clinical Scholarship and the Ryan Gibson Foundation Award. 

He has also served as a member of the American Association for the Advancement of Science and the American Association for Cancer Research. He holds several patents, and his research and editorial content has been published in over 40 peer-reviewed journals, including Nature, Cell and Cancer Research

 back to list | back to top